Industry Research Reports

Home > Reports > Pharma & Healthcare > Global Donepezil Market Research Report 2025

Global Donepezil Market Research Report 2025

Industry: Pharma & Healthcare

Published Date: 2025-10-17

Pages: 89 Pages

Report ld: 3470686

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Donepezil Market Size(US$)

CAGR 2025-2031

1.6%

Market Size,2031

USD 970

Million

Market Snapshot

Market Size in 2025 (Value)

US$ 881 million

Market Forecast in 2031(Value)

US$ 970 million

CAGR

1.6%

Years Considered

2020-2031

Base Year

2025

Forecast Period

2025-2031

Source: Secondary research, interviews with experts, and QYResearch analysis

The global market for Donepezil was valued at US$ 886 million in the year 2024 and is projected to reach a revised size of US$ 970 million by 2031, growing at a CAGR of 1.6% during the forecast period.

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Donepezil competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.

Donepezil is a selective and reversible acetylcholinesterase inhibitor primarily used to treat cognitive impairment in patients with Alzheimer’s disease (AD). By inhibiting the breakdown of acetylcholine in the brain, it enhances neurotransmitter levels, thereby improving memory, learning, and behavioral functions. Since its launch in the 1990s, Donepezil has become one of the most widely used therapeutic agents for Alzheimer’s disease globally, available in oral tablets, orally disintegrating tablets, and transdermal patch formulations. It features stable pharmacological properties and a favorable safety profile, offering good compliance in long-term management of mild to moderate AD. With population aging and the rising prevalence of neurodegenerative disorders, the market value of Donepezil continues to expand, consolidating its position as a cornerstone drug in the neurological therapeutics sector.In 2024, global Donepezil production reached approximately 1772 m units, with an average global market price of around US$ 0.5 perunit.The average gross profit margin for this product is 60%.

With the acceleration of global population aging and improved diagnosis rates of Alzheimer’s disease, the Donepezil market is entering a new phase of growth. Many healthcare systems have integrated cognitive disorder management into chronic disease programs, increasing accessibility and reimbursement coverage. In addition, formulation innovations such as orally disintegrating tablets and long-acting transdermal patches enhance patient convenience and compliance, creating new competitive advantages. Meanwhile, faster drug registration and generic approval processes in emerging markets—especially across Asia—are opening strategic windows for local players, driving further globalization of the supply chain.Despite its growth potential, Donepezil faces challenges from patent expirations and intensified generic competition. Stricter drug tendering systems in several countries continue to push down average prices, squeezing profit margins. Furthermore, the emergence of novel Alzheimer’s therapies—such as β-amyloid antibodies and tau protein modulators—may reshape the therapeutic landscape, posing potential substitution threats. Increasing regulatory requirements for quality consistency and pharmacovigilance also demand more advanced production and compliance systems from manufacturers.Clinically, Donepezil remains one of the first-line treatments for mild to moderate Alzheimer’s disease, particularly in primary care and long-term care facilities. As public awareness of cognitive disorders grows and early screening expands, the number of mild cases continues to rise, ensuring stable demand. National healthcare policies increasingly encourage the use of generic medications, benefiting domestic manufacturers. Meanwhile, research into new indications—such as Parkinson’s-related dementia and vascular cognitive impairment—offers new growth momentum for the market.Key raw materials for Donepezil include piperidine intermediates, benzothiazole derivatives, and multiple organic solvents and catalysts required in multistep synthesis. With tightening environmental regulations, optimization of synthetic pathways for core intermediates has become a cost-control priority. The upstream sector is moving toward high-purity, high-yield, and greener synthesis processes to meet pharmacopeia standards in Europe, the U.S., and Japan. Leading global suppliers are integrating APIs and finished dosage forms to ensure stable raw material supply and mitigate production volatility.

biaoTi REPORT SCOPE

This report aims to provide a comprehensive presentation of the global market for Donepezil, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Donepezil.

The Donepezil market size, estimations, and forecasts are provided in terms of sales volume (M Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Donepezil market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Donepezil manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

By Company

Eisai

Pfizer

Teva

Sandoz

Apotex

Dr Reddy's Laboratories

Sun Pharmaceutical

Hansoh Pharma

Cipla

ARK PHA.LTD

Ruien Pharma

Luoxin

Torrent Pharmaceuticals

Zhejiang Huahai Pharma

Daewoong Pharmaceutical

Segment by Type

5mg

10mg

23mg

Segment by Application

Hospitals

Clinics

Drugstore

Consumption by Region

North America

U.S.

Canada

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Indonesia

Thailand

Malaysia

Philippines

Vietnam

Europe

Germany

France

U.K.

Italy

Russia

Latin America

Mexico

Brazil

Argentina

Middle East and Africa

Turkey

Saudi Arabia

U.A.E

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Detailed analysis of Donepezil manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Sales, revenue of Donepezil in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 9: The main points and conclusions of the report.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Donepezil Market Overview

1.1 Product Definition

1.2 Donepezil by Type

1.2.1 Global Donepezil Market Value Comparison by Type (2024 VS 2031)

1.2.2 5mg

1.2.3 10mg

1.2.4 23mg

1.3 Donepezil by Application

1.3.1 Global Donepezil Market Value by Application (2024 VS 2031)

1.3.2 Hospitals

1.3.3 Clinics

1.3.4 Drugstore

1.4 Global Donepezil Market Size Estimates and Forecasts

1.4.1 Global Donepezil Revenue 2020-2031

1.4.2 Global Donepezil Sales 2020-2031

1.4.3 Global Donepezil Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Donepezil Market Competition by Manufacturers

2.1 Global Donepezil Sales Market Share by Manufacturers (2020-2025)

2.2 Global Donepezil Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Donepezil Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Donepezil, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Donepezil, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Donepezil, Product Type & Application

2.7 Global Key Manufacturers of Donepezil, Date of Enter into This Industry

2.8 Global Donepezil Market Competitive Situation and Trends

2.8.1 Global Donepezil Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Donepezil Players Market Share by Revenue

2.8.3 Global Donepezil Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Donepezil Market Scenario by Region

3.1 Global Donepezil Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Donepezil Sales by Region: 2020-2031

3.2.1 Global Donepezil Sales by Region: 2020-2025

3.2.2 Global Donepezil Sales by Region: 2026-2031

3.3 Global Donepezil Revenue by Region: 2020-2031

3.3.1 Global Donepezil Revenue by Region: 2020-2025

3.3.2 Global Donepezil Revenue by Region: 2026-2031

3.4 North America Donepezil Market Facts & Figures by Country

3.4.1 North America Donepezil Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Donepezil Sales by Country (2020-2031)

3.4.3 North America Donepezil Revenue by Country (2020-2031)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Donepezil Market Facts & Figures by Country

3.5.1 Europe Donepezil Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Donepezil Sales by Country (2020-2031)

3.5.3 Europe Donepezil Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Donepezil Market Facts & Figures by Region

3.6.1 Asia Pacific Donepezil Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Donepezil Sales by Region (2020-2031)

3.6.3 Asia Pacific Donepezil Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Donepezil Market Facts & Figures by Country

3.7.1 Latin America Donepezil Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Donepezil Sales by Country (2020-2031)

3.7.3 Latin America Donepezil Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Donepezil Market Facts & Figures by Country

3.8.1 Middle East and Africa Donepezil Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Donepezil Sales by Country (2020-2031)

3.8.3 Middle East and Africa Donepezil Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 U.A.E

4 Segment by Type

4.1 Global Donepezil Sales by Type (2020-2031)

4.1.1 Global Donepezil Sales by Type (2020-2025)

4.1.2 Global Donepezil Sales by Type (2026-2031)

4.1.3 Global Donepezil Sales Market Share by Type (2020-2031)

4.2 Global Donepezil Revenue by Type (2020-2031)

4.2.1 Global Donepezil Revenue by Type (2020-2025)

4.2.2 Global Donepezil Revenue by Type (2026-2031)

4.2.3 Global Donepezil Revenue Market Share by Type (2020-2031)

4.3 Global Donepezil Price by Type (2020-2031)

5 Segment by Application

5.1 Global Donepezil Sales by Application (2020-2031)

5.1.1 Global Donepezil Sales by Application (2020-2025)

5.1.2 Global Donepezil Sales by Application (2026-2031)

5.1.3 Global Donepezil Sales Market Share by Application (2020-2031)

5.2 Global Donepezil Revenue by Application (2020-2031)

5.2.1 Global Donepezil Revenue by Application (2020-2025)

5.2.2 Global Donepezil Revenue by Application (2026-2031)

5.2.3 Global Donepezil Revenue Market Share by Application (2020-2031)

5.3 Global Donepezil Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Eisai

6.1.1 Eisai Company Information

6.1.2 Eisai Description and Business Overview

6.1.3 Eisai Donepezil Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Eisai Donepezil Product Portfolio

6.1.5 Eisai Recent Developments/Updates

6.2 Pfizer

6.2.1 Pfizer Company Information

6.2.2 Pfizer Description and Business Overview

6.2.3 Pfizer Donepezil Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Pfizer Donepezil Product Portfolio

6.2.5 Pfizer Recent Developments/Updates

6.3 Teva

6.3.1 Teva Company Information

6.3.2 Teva Description and Business Overview

6.3.3 Teva Donepezil Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Teva Donepezil Product Portfolio

6.3.5 Teva Recent Developments/Updates

6.4 Sandoz

6.4.1 Sandoz Company Information

6.4.2 Sandoz Description and Business Overview

6.4.3 Sandoz Donepezil Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Sandoz Donepezil Product Portfolio

6.4.5 Sandoz Recent Developments/Updates

6.5 Apotex

6.5.1 Apotex Company Information

6.5.2 Apotex Description and Business Overview

6.5.3 Apotex Donepezil Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Apotex Donepezil Product Portfolio

6.5.5 Apotex Recent Developments/Updates

6.6 Dr Reddy's Laboratories

6.6.1 Dr Reddy's Laboratories Company Information

6.6.2 Dr Reddy's Laboratories Description and Business Overview

6.6.3 Dr Reddy's Laboratories Donepezil Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Dr Reddy's Laboratories Donepezil Product Portfolio

6.6.5 Dr Reddy's Laboratories Recent Developments/Updates

6.7 Sun Pharmaceutical

6.7.1 Sun Pharmaceutical Company Information

6.7.2 Sun Pharmaceutical Description and Business Overview

6.7.3 Sun Pharmaceutical Donepezil Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Sun Pharmaceutical Donepezil Product Portfolio

6.7.5 Sun Pharmaceutical Recent Developments/Updates

6.8 Hansoh Pharma

6.8.1 Hansoh Pharma Company Information

6.8.2 Hansoh Pharma Description and Business Overview

6.8.3 Hansoh Pharma Donepezil Sales, Revenue and Gross Margin (2020-2025)

6.8.4 Hansoh Pharma Donepezil Product Portfolio

6.8.5 Hansoh Pharma Recent Developments/Updates

6.9 Cipla

6.9.1 Cipla Company Information

6.9.2 Cipla Description and Business Overview

6.9.3 Cipla Donepezil Sales, Revenue and Gross Margin (2020-2025)

6.9.4 Cipla Donepezil Product Portfolio

6.9.5 Cipla Recent Developments/Updates

6.10 ARK PHA.LTD

6.10.1 ARK PHA.LTD Company Information

6.10.2 ARK PHA.LTD Description and Business Overview

6.10.3 ARK PHA.LTD Donepezil Sales, Revenue and Gross Margin (2020-2025)

6.10.4 ARK PHA.LTD Donepezil Product Portfolio

6.10.5 ARK PHA.LTD Recent Developments/Updates

6.11 Ruien Pharma

6.11.1 Ruien Pharma Company Information

6.11.2 Ruien Pharma Description and Business Overview

6.11.3 Ruien Pharma Donepezil Sales, Revenue and Gross Margin (2020-2025)

6.11.4 Ruien Pharma Donepezil Product Portfolio

6.11.5 Ruien Pharma Recent Developments/Updates

6.12 Luoxin

6.12.1 Luoxin Company Information

6.12.2 Luoxin Description and Business Overview

6.12.3 Luoxin Donepezil Sales, Revenue and Gross Margin (2020-2025)

6.12.4 Luoxin Donepezil Product Portfolio

6.12.5 Luoxin Recent Developments/Updates

6.13 Torrent Pharmaceuticals

6.13.1 Torrent Pharmaceuticals Company Information

6.13.2 Torrent Pharmaceuticals Description and Business Overview

6.13.3 Torrent Pharmaceuticals Donepezil Sales, Revenue and Gross Margin (2020-2025)

6.13.4 Torrent Pharmaceuticals Donepezil Product Portfolio

6.13.5 Torrent Pharmaceuticals Recent Developments/Updates

6.14 Zhejiang Huahai Pharma

6.14.1 Zhejiang Huahai Pharma Company Information

6.14.2 Zhejiang Huahai Pharma Description and Business Overview

6.14.3 Zhejiang Huahai Pharma Donepezil Sales, Revenue and Gross Margin (2020-2025)

6.14.4 Zhejiang Huahai Pharma Donepezil Product Portfolio

6.14.5 Zhejiang Huahai Pharma Recent Developments/Updates

6.15 Daewoong Pharmaceutical

6.15.1 Daewoong Pharmaceutical Company Information

6.15.2 Daewoong Pharmaceutical Description and Business Overview

6.15.3 Daewoong Pharmaceutical Donepezil Sales, Revenue and Gross Margin (2020-2025)

6.15.4 Daewoong Pharmaceutical Donepezil Product Portfolio

6.15.5 Daewoong Pharmaceutical Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Donepezil Industry Chain Analysis

7.2 Donepezil Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Donepezil Production Mode & Process Analysis

7.4 Donepezil Sales and Marketing

7.4.1 Donepezil Sales Channels

7.4.2 Donepezil Distributors

7.5 Donepezil Customer Analysis

8 Donepezil Market Dynamics

8.1 Donepezil Industry Trends

8.2 Donepezil Market Drivers

8.3 Donepezil Market Challenges

8.4 Donepezil Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Global Donepezil Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Donepezil Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Donepezil Market Competitive Situation by Manufacturers in 2024

Table 4. Global Donepezil Sales (M Units) of Key Manufacturers (2020-2025)

Table 5. Global Donepezil Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Donepezil Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Donepezil Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Donepezil Average Price (US$/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Donepezil, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Donepezil, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Donepezil, Product Type & Application

Table 12. Global Key Manufacturers of Donepezil, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Donepezil by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Donepezil as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Donepezil Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Donepezil Sales by Region (2020-2025) & (M Units)

Table 18. Global Donepezil Sales Market Share by Region (2020-2025)

Table 19. Global Donepezil Sales by Region (2026-2031) & (M Units)

Table 20. Global Donepezil Sales Market Share by Region (2026-2031)

Table 21. Global Donepezil Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Donepezil Revenue Market Share by Region (2020-2025)

Table 23. Global Donepezil Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Donepezil Revenue Market Share by Region (2026-2031)

Table 25. North America Donepezil Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Donepezil Sales by Country (2020-2025) & (M Units)

Table 27. North America Donepezil Sales by Country (2026-2031) & (M Units)

Table 28. North America Donepezil Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Donepezil Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Donepezil Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Donepezil Sales by Country (2020-2025) & (M Units)

Table 32. Europe Donepezil Sales by Country (2026-2031) & (M Units)

Table 33. Europe Donepezil Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Donepezil Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Donepezil Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Donepezil Sales by Region (2020-2025) & (M Units)

Table 37. Asia Pacific Donepezil Sales by Region (2026-2031) & (M Units)

Table 38. Asia Pacific Donepezil Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Donepezil Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Donepezil Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Donepezil Sales by Country (2020-2025) & (M Units)

Table 42. Latin America Donepezil Sales by Country (2026-2031) & (M Units)

Table 43. Latin America Donepezil Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Donepezil Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Donepezil Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Donepezil Sales by Country (2020-2025) & (M Units)

Table 47. Middle East and Africa Donepezil Sales by Country (2026-2031) & (M Units)

Table 48. Middle East and Africa Donepezil Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Donepezil Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Donepezil Sales (M Units) by Type (2020-2025)

Table 51. Global Donepezil Sales (M Units) by Type (2026-2031)

Table 52. Global Donepezil Sales Market Share by Type (2020-2025)

Table 53. Global Donepezil Sales Market Share by Type (2026-2031)

Table 54. Global Donepezil Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Donepezil Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Donepezil Revenue Market Share by Type (2020-2025)

Table 57. Global Donepezil Revenue Market Share by Type (2026-2031)

Table 58. Global Donepezil Price (US$/Unit) by Type (2020-2025)

Table 59. Global Donepezil Price (US$/Unit) by Type (2026-2031)

Table 60. Global Donepezil Sales (M Units) by Application (2020-2025)

Table 61. Global Donepezil Sales (M Units) by Application (2026-2031)

Table 62. Global Donepezil Sales Market Share by Application (2020-2025)

Table 63. Global Donepezil Sales Market Share by Application (2026-2031)

Table 64. Global Donepezil Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Donepezil Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Donepezil Revenue Market Share by Application (2020-2025)

Table 67. Global Donepezil Revenue Market Share by Application (2026-2031)

Table 68. Global Donepezil Price (US$/Unit) by Application (2020-2025)

Table 69. Global Donepezil Price (US$/Unit) by Application (2026-2031)

Table 70. Eisai Company Information

Table 71. Eisai Description and Business Overview

Table 72. Eisai Donepezil Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 73. Eisai Donepezil Product

Table 74. Eisai Recent Developments/Updates

Table 75. Pfizer Company Information

Table 76. Pfizer Description and Business Overview

Table 77. Pfizer Donepezil Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 78. Pfizer Donepezil Product

Table 79. Pfizer Recent Developments/Updates

Table 80. Teva Company Information

Table 81. Teva Description and Business Overview

Table 82. Teva Donepezil Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 83. Teva Donepezil Product

Table 84. Teva Recent Developments/Updates

Table 85. Sandoz Company Information

Table 86. Sandoz Description and Business Overview

Table 87. Sandoz Donepezil Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 88. Sandoz Donepezil Product

Table 89. Sandoz Recent Developments/Updates

Table 90. Apotex Company Information

Table 91. Apotex Description and Business Overview

Table 92. Apotex Donepezil Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 93. Apotex Donepezil Product

Table 94. Apotex Recent Developments/Updates

Table 95. Dr Reddy's Laboratories Company Information

Table 96. Dr Reddy's Laboratories Description and Business Overview

Table 97. Dr Reddy's Laboratories Donepezil Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 98. Dr Reddy's Laboratories Donepezil Product

Table 99. Dr Reddy's Laboratories Recent Developments/Updates

Table 100. Sun Pharmaceutical Company Information

Table 101. Sun Pharmaceutical Description and Business Overview

Table 102. Sun Pharmaceutical Donepezil Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 103. Sun Pharmaceutical Donepezil Product

Table 104. Sun Pharmaceutical Recent Developments/Updates

Table 105. Hansoh Pharma Company Information

Table 106. Hansoh Pharma Description and Business Overview

Table 107. Hansoh Pharma Donepezil Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 108. Hansoh Pharma Donepezil Product

Table 109. Hansoh Pharma Recent Developments/Updates

Table 110. Cipla Company Information

Table 111. Cipla Description and Business Overview

Table 112. Cipla Donepezil Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 113. Cipla Donepezil Product

Table 114. Cipla Recent Developments/Updates

Table 115. ARK PHA.LTD Company Information

Table 116. ARK PHA.LTD Description and Business Overview

Table 117. ARK PHA.LTD Donepezil Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 118. ARK PHA.LTD Donepezil Product

Table 119. ARK PHA.LTD Recent Developments/Updates

Table 120. Ruien Pharma Company Information

Table 121. Ruien Pharma Description and Business Overview

Table 122. Ruien Pharma Donepezil Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 123. Ruien Pharma Donepezil Product

Table 124. Ruien Pharma Recent Developments/Updates

Table 125. Luoxin Company Information

Table 126. Luoxin Description and Business Overview

Table 127. Luoxin Donepezil Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 128. Luoxin Donepezil Product

Table 129. Luoxin Recent Developments/Updates

Table 130. Torrent Pharmaceuticals Company Information

Table 131. Torrent Pharmaceuticals Description and Business Overview

Table 132. Torrent Pharmaceuticals Donepezil Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 133. Torrent Pharmaceuticals Donepezil Product

Table 134. Torrent Pharmaceuticals Recent Developments/Updates

Table 135. Zhejiang Huahai Pharma Company Information

Table 136. Zhejiang Huahai Pharma Description and Business Overview

Table 137. Zhejiang Huahai Pharma Donepezil Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 138. Zhejiang Huahai Pharma Donepezil Product

Table 139. Zhejiang Huahai Pharma Recent Developments/Updates

Table 140. Daewoong Pharmaceutical Company Information

Table 141. Daewoong Pharmaceutical Description and Business Overview

Table 142. Daewoong Pharmaceutical Donepezil Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 143. Daewoong Pharmaceutical Donepezil Product

Table 144. Daewoong Pharmaceutical Recent Developments/Updates

Table 145. Key Raw Materials Lists

Table 146. Raw Materials Key Suppliers Lists

Table 147. Donepezil Distributors List

Table 148. Donepezil Customers List

Table 149. Donepezil Market Trends

Table 150. Donepezil Market Drivers

Table 151. Donepezil Market Challenges

Table 152. Donepezil Market Restraints

Table 153. Research Programs/Design for This Report

Table 154. Key Data Information from Secondary Sources

Table 155. Key Data Information from Primary Sources

Table 156. Authors List of This Report

List of Figures

Figure 1. Product Picture of Donepezil

Figure 2. Global Donepezil Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Donepezil Market Share by Type: 2024 & 2031

Figure 4. 5mg Product Picture

Figure 5. 10mg Product Picture

Figure 6. 23mg Product Picture

Figure 7. Global Donepezil Market Value by Application (2020-2031) & (US$ Million)

Figure 8. Global Donepezil Market Share by Application: 2024 & 2031

Figure 9. Hospitals

Figure 10. Clinics

Figure 11. Drugstore

Figure 12. Global Donepezil Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 13. Global Donepezil Market Size (2020-2031) & (US$ Million)

Figure 14. Global Donepezil Sales (2020-2031) & (M Units)

Figure 15. Global Donepezil Average Price (US$/Unit) & (2020-2031)

Figure 16. Donepezil Report Years Considered

Figure 17. Donepezil Sales Share by Manufacturers in 2024

Figure 18. Global Donepezil Revenue Share by Manufacturers in 2024

Figure 19. Global 5 and 10 Largest Donepezil Players: Market Share by Revenue in Donepezil in 2024

Figure 20. Donepezil Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 21. Global Donepezil Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 22. North America Donepezil Sales Market Share by Country (2020-2031)

Figure 23. North America Donepezil Revenue Market Share by Country (2020-2031)

Figure 24. U.S. Donepezil Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 25. Canada Donepezil Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 26. Europe Donepezil Sales Market Share by Country (2020-2031)

Figure 27. Europe Donepezil Revenue Market Share by Country (2020-2031)

Figure 28. Germany Donepezil Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. France Donepezil Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. U.K. Donepezil Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. Italy Donepezil Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. Russia Donepezil Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 33. Asia Pacific Donepezil Sales Market Share by Region (2020-2031)

Figure 34. Asia Pacific Donepezil Revenue Market Share by Region (2020-2031)

Figure 35. China Donepezil Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. Japan Donepezil Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. South Korea Donepezil Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. India Donepezil Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. Australia Donepezil Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. China Taiwan Donepezil Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Indonesia Donepezil Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Thailand Donepezil Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Malaysia Donepezil Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Philippines Donepezil Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Latin America Donepezil Sales Market Share by Country (2020-2031)

Figure 46. Latin America Donepezil Revenue Market Share by Country (2020-2031)

Figure 47. Mexico Donepezil Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 48. Brazil Donepezil Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 49. Argentina Donepezil Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 50. Middle East and Africa Donepezil Sales Market Share by Country (2020-2031)

Figure 51. Middle East and Africa Donepezil Revenue Market Share by Country (2020-2031)

Figure 52. Turkey Donepezil Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 53. Saudi Arabia Donepezil Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 54. U.A.E Donepezil Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 55. Global Sales Market Share of Donepezil by Type (2020-2031)

Figure 56. Global Revenue Market Share of Donepezil by Type (2020-2031)

Figure 57. Global Donepezil Price (US$/Unit) by Type (2020-2031)

Figure 58. Global Sales Market Share of Donepezil by Application (2020-2031)

Figure 59. Global Revenue Market Share of Donepezil by Application (2020-2031)

Figure 60. Global Donepezil Price (US$/Unit) by Application (2020-2031)

Figure 61. Donepezil Value Chain

Figure 62. Channels of Distribution (Direct Vs Distribution)

Figure 63. Bottom-up and Top-down Approaches for This Report

Figure 64. Data Triangulation

Figure 65. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global Donepezil market? zhanKai

The top companies in the global Donepezil market are Eisai、Pfizer、Teva.

What was the global market size of Donepezil in 2031? shouQi

What is the annual compound growth rate of the global Donepezil market size from 2025 to 2031? shouQi

Which region is expected to have the highest market share? shouQi

What was the global market size of Donepezil in 2025? shouQi

Related Reports

Global Donepezil Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Donepezil market size was US$ 881 million in 2025 and is forecast to reach a readjusted size of US$ 983 million by 2032 with a CAGR of 1.6% during the forecast period 2026-2032.
Published Date: 2026-01-04
Pages: 95
USD 4250.00
(Single User License)
Global Donepezil Market Research Report 2026
The global Donepezil market was valued at US$ 881 million in 2025 and is anticipated to reach US$ 983 million by 2032, at a CAGR of 1.6% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 126
USD 2900.00
(Single User License)
Donepezil- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Donepezil was estimated to be worth US$ 881 million in 2025 and is projected to reach US$ 983 million, growing at a CAGR of 1.6% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 120
USD 3950.00
(Single User License)
Donepezil - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Donepezil was estimated to be worth US$ 886 million in 2024 and is forecast to a readjusted size of US$ 970 million by 2031 with a CAGR of 1.6% during the forecast period 2025-2031.
Published Date: 2025-10-17
Pages: 115
USD 3950.00
(Single User License)
Global Donepezil Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Donepezil market is projected to grow from US$ 886 million in 2024 to US$ 970 million by 2031, at a CAGR of 1.6% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-10-17
Pages: 162
USD 4900.00
(Single User License)
Global Donepezil Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Donepezil market size was US$ 886 million in 2024 and is forecast to a readjusted size of US$ 970 million by 2031 with a CAGR of 1.6% during the forecast period 2025-2031.
Published Date: 2025-10-17
Pages: 99
USD 4250.00
(Single User License)
Global Donepezil Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Donepezil was estimated to be worth US$ 886 million and is forecast to reach approximately US$ 850 million by 2031 with a CAGR of -0.6% during the forecast period 2025-2031.
Published Date: 2025-03-28
Pages: 149
USD 5900.00
(Single User License)
Donepezil- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Donepezil was estimated to be worth US$ 886 million in 2024 and is forecast to a readjusted size of US$ 850 million by 2031 with a CAGR of -0.6% during the forecast period 2025-2031.
Published Date: 2025-01-16
Pages: 111
USD 3950.00
(Single User License)
Global Donepezil Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
North America is the main market for donepezil, accounting for about 35% of the total market, followed by Europe with about 30%.
Published Date: 2024-04-17
Pages: 167
USD 5600.00
(Single User License)
Global Donepezil Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
North America is the main market for donepezil, accounting for about 35% of the total market, followed by Europe with about 30%.
Published Date: 2024-04-16
Pages: 151
USD 5900.00
(Single User License)

Global Donepezil Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Donepezil market size was US$ 881 million in 2025 and is forecast to reach a readjusted size of US$ 983 million by 2032 with a CAGR of 1.6% during the forecast period 2026-2032.
Published: 2026-01-04
Pages: 95
USD 4250.00 (Single User License)
Global Donepezil Market Research Report 2026
The global Donepezil market was valued at US$ 881 million in 2025 and is anticipated to reach US$ 983 million by 2032, at a CAGR of 1.6% from 2026 to 2032.
Published: 2026-01-04
Pages: 126
USD 2900.00 (Single User License)
Donepezil- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Donepezil was estimated to be worth US$ 881 million in 2025 and is projected to reach US$ 983 million, growing at a CAGR of 1.6% from 2026 to 2032.
Published: 2026-01-04
Pages: 120
USD 3950.00 (Single User License)
Donepezil - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Donepezil was estimated to be worth US$ 886 million in 2024 and is forecast to a readjusted size of US$ 970 million by 2031 with a CAGR of 1.6% during the forecast period 2025-2031.
Published: 2025-10-17
Pages: 115
USD 3950.00 (Single User License)
Global Donepezil Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Donepezil market is projected to grow from US$ 886 million in 2024 to US$ 970 million by 2031, at a CAGR of 1.6% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-17
Pages: 162
USD 4900.00 (Single User License)
Global Donepezil Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Donepezil market size was US$ 886 million in 2024 and is forecast to a readjusted size of US$ 970 million by 2031 with a CAGR of 1.6% during the forecast period 2025-2031.
Published: 2025-10-17
Pages: 99
USD 4250.00 (Single User License)
Global Donepezil Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Donepezil was estimated to be worth US$ 886 million and is forecast to reach approximately US$ 850 million by 2031 with a CAGR of -0.6% during the forecast period 2025-2031.
Published: 2025-03-28
Pages: 149
USD 5900.00 (Single User License)
Donepezil- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Donepezil was estimated to be worth US$ 886 million in 2024 and is forecast to a readjusted size of US$ 850 million by 2031 with a CAGR of -0.6% during the forecast period 2025-2031.
Published: 2025-01-16
Pages: 111
USD 3950.00 (Single User License)
Global Donepezil Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
North America is the main market for donepezil, accounting for about 35% of the total market, followed by Europe with about 30%.
Published: 2024-04-17
Pages: 167
USD 5600.00 (Single User License)
Global Donepezil Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
North America is the main market for donepezil, accounting for about 35% of the total market, followed by Europe with about 30%.
Published: 2024-04-16
Pages: 151
USD 5900.00 (Single User License)